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Abstract
Background: Germ cell tumors (GCTs) in children are rare neoplasms with diverse pathological findings according to
the site and age of presentation. The most common symptoms in children with mediastinal GCTs, which are nonspecific,
are dyspnea, chest pain, cough, hemoptysis, vena cava occlusion syndrome, and fatigue/weakness. Because of these
nonspecific symptoms, it is difficult to suspect a mediastinal mass. A posterior mediastinal tumor causing spinal cord
compression is an important example of an oncologic emergency arising from a neurogenic tumor.
Case presentation: Children with posterior mediastinum GCTs can be easily mistaken as having a neurogenic tumor
because of site of tumor origin. We treated our 7-year-old patient with emergency decompression surgery and high-
dose steroid pulse therapy to prevent secondary injury to the spinal cord. Primary injury was a result of spinal cord
compression due to the initial manifestation of GCT in the posterior mediastinum. Cisplatin-based chemotherapy was
also administered. The patient was followed up regularly for 3 years and is undergoing rehabilitation without any signs
of recurrence.
Conclusions: We present an extremely rare case of a child with paraparesis caused by extradural spinal cord
compression as the initial manifestation of GCT in the posterior mediastinum. The child was treated with emergency
decompression surgery and high-dose pulse steroid therapy to prevent secondary injury to the spinal cord.
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Background
Germ cell tumors (GCTs) in children are rare neoplasms
with diverse pathological findings according to the site
and age of presentation. Pediatric GCTs predominantly
occur in the midline of the trunk: in the intracranium,
mediastinum, gonads, and sacrococcygeum. Histologic
subtypes of mediastinal GCTs in children include mature
teratoma, 60%; mixed GCTs, 20%; and embryonal carcin-
oma, 20% (including seminoma/germinoma, immature
teratoma, yolk sac tumor, and choriocarcinoma). About
5% of all extragonadal germ cell tumors originate from the
mediastinum in children younger than 15 years [1, 2].
The most common symptoms of mediastinal GCTs
in children are dyspnea, chest pain, cough, hemoptysis,
vena cava occlusion syndrome, and fatigue/weakness
[3, 4]. Although survival rates of pediatric GCTs have
improved significantly to 80% among patients who
receive platinum-based chemotherapy, detection of
mediastinal GCTs is challenging because of these non-
specific symptoms. In this article, we report an ex-
tremely rare pediatric case of paraparesis caused by
extradural spinal cord compression as the initial mani-
festation of GCT in the posterior mediastinum. This
case illustrates the importance of promptness and
treatment method, and the prognosis of spinal cord
compression caused by GCTs.
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Case presentation
We report the case of a 7-year-old boy, who was healthy
until the age of 6 years when he presented to a local
hospital with progressive intermittent back pain (grade 4
on the Numeric Rating Scale), leg weakness, and poor
appetite. Within a month, he was admitted to our
pediatric emergency department because he could no
longer stand without assistance. At that time, he had
no bladder and bowel dysfunction and no history of
trauma. On neurological examination, he had signifi-
cant lower extremity weakness, with a grade 3 in both
legs on the Medical Research Council (MRC) scale
and with preservation of sensory function. Moreover,
he had positive Babinski reflexes in his lower extrem-
ities and the presence of ankle clonus. We planned an
emergency imaging examination, suspecting spinal
cord compression syndrome.
Magnetic resonance imaging (MRI) of the thoracic
spine and computed tomography (CT) of the chest re-
vealed a large mass sized 6.1 × 7.4 × 9.5 cm in the right
posterior mediastinum from T5 to T11, involving T8
and the T9 vertebral body with extension into the spinal
canal and compressing the spinal cord (Fig. 1a, b).
Moreover, the tumor showed septal contrast enhance-
ment on coronal T2 view of the thoracic spine MRI
and internal dystrophic calcification on the chest CT
(Fig. 1c, d). No metastasis was observed on examin-
ation with bone scintigraphy, positron emission tom-
ography–CT, and testicular sonography.
Emergency total laminectomy for T6-T10 was per-
formed and histopathological examination of the speci-
men confirmed a seminoma in the posterior mediastinum.
Immunohistochemical staining result was negative for β-
human chorionic gonadotropin (HCG), but positive for
placental alkaline phosphatase (PALP) and c-KIT (CD117)
in the tumor cells (Fig. 2).
Complete blood cell count and an admission panel test
revealed no abnormal findings, including levels of lactate
dehydrogenase 547 U/L, α-fetoprotein (AFP) < 1.3 ng/
mL, and alkaline phosphatase (ALP) 172 U/L (PALP
portion was not found). However, β-HCG level was high
(30.84 mIU/mL, reference range 0–10 mIU/mL). The
patient was treated with methylprednisolone pulse therapy
(30 mg/kg/day) postoperatively for 30 h, subsequently
followed by maintenance therapy with oral prednisolone
for 2 weeks, as well as rehabilitation. Nine cycles of chemo-
therapy were administered postoperatively, followed by
5 cycles of ICE (Ifosfamide 1500 mg/m2/day IV on days 1-
5, Carboplatin 150 mg/m2/day IV on days 1-2, Etoposide
100 mg/m2/day IV on days 1-5) and 4 cycles of BEP
Fig. 1 a Sagittal T1 and b T2-weighted MRI scans of the thoracic spine reveal a large mass sized 6.1 × 7.4 × 9.5 cm in the right posterior mediastinum
from T5-T11, involving the T8 and T9 vertebral body with extension into the spinal canal and compressing the spinal cord. The tumor had a vertebra
plana appearance and shows mixed osteolytic and sclerotic bone destruction. c The tumor shows septal contrast enhancement on the coronal T2 view
and d internal dystrophic calcification on CT of the chest. e On day + 28 (before the 2nd cycle of chemotherapy), a thoracic spine MRI shows a
much-decreased soft tissue tumor in the right posterior mediastinum at T5-T11 level with a residual lesion after removal in the spinal canal from the
lower T5 -T9 level with total laminectomy from T6-T10 vertebra. f On day + 286 (after the 9th cycle of chemotherapy), a sagittal T2-weighted MRI on
follow-up shows that the soft tissue tumor had almost disappeared from the right posterior mediastinal and intercostal space compared with the
previous MRIs
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(Bleomycin 15 mg/m2/day IV on day 1, Etoposide
100 mg/m2/day IV on days 1-5, Cisplatin 20 mg/m2/
day IV on days 1-5) alternatively (Fig. 3).
On day 28 (+ 28) after starting chemotherapy, before
the 2nd cycle of chemotherapy, β-HCG was undetect-
able in the blood. Moreover, a thoracic spine MRI
showed a much decreased soft tissue tumor in the right
posterior mediastinum at T5-T11 level with a residual
lesion after removal in the spinal canal from lower T5-
T9 level, with the total laminectomy from the T6-T10
vertebra (Fig. 1e).
He underwent video-assisted thoracoscopic exploration
and biopsy on day + 91 (after the 3rd cycle of chemother-
apy). A grossly visible tumor was not detected and the
tissue specimen was free of tumor microscopically.
After the last (ninth) cycle of chemotherapy (on day +
286), a spine MRI revealed an improved state of compres-
sive myelopathy at the T7-T9 region and that the soft
tissue tumor had almost disappeared from the posterior
mediastinal and intercostal space compared with the ini-
tial MRI (Fig. 1f).
The patient has been undergoing regular physical
therapy and regular follow ups for 3 years since the
chemotherapy ended. On day + 1129, there was no
abnormality except for a mild kyphotic curvature on
the spine MRI. Moreover, the patient slowly recov-
ered from the neurologic symptoms, improving to
grade 4 in lower extremity strength on the MRC
scale, and could walk without assistance. He has
been wearing a thoracolumbosacral orthosis brace
Fig. 2 a Photomicrograph of the surgical specimen showing that the tumor consisted of uniform cells divided into clusters by fine fibrous
trabeculae associated with a lymphocytic infiltrate (H&E, 200X). b Round or polygonal seminoma cells with a distinct membrane (H&E, 400X).
c Immunohistochemical staining with β-HCG. The tumor cells were negative for β-HCG (β-HCG, 400X). d Seminoma stained with PALP
(PALP, 400X). e c-KIT showed diffuse positivity in the malignant cells. (c-KIT, 400X)
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for kyphotic curvature prevention and is undergoing
multidisciplinary rehabilitation.
Discussion and conclusion
Spinal cord compression requires accurate diagnosis and
rapid treatment to prevent progression to irreversible
nerve injury. The most common etiologies of spinal cord
compression are lumbar disc herniation, spinal stenosis,
and masses including primary and metastatic tumor.
The warning signs of back pain identified as spinal cord
compression show profound unexplained neurological
deficits such as motor or sensory weakness in the lower
extremity, recent bowel or bladder dysfunction, and
suggest non-musculoskeletal disorders [5]. Additionally,
it may be helpful to examine the Babinski sign, presence
of clonus, and increased deep tendon reflexes to make a
diagnosis.
If the spine is in an unstable condition due to direct
compression, which may result in edema, venous con-
gestion, and demyelination, immediate decompression
surgery is required for remyelination and recovery of
neurologic function [6]. After prolonged compression of
the spine and occurrence of spinal cord infarction, it is
not possible to achieve a meaningful recovery. However,
the optimal treatment for spinal cord compression
caused by a primary tumor in children is unclear in a
non-emergency condition. The risk of spinal deformity
after multi-modality treatment must be considered
carefully, especially in younger children [7]. Particularly,
radiation therapy for spinal cord compression in younger
children was carefully considered because of the poten-
tially irreversible complications of radiation therapy such
as spinal deformity, neurological sequelae, and secondary
malignant diseases like radiation-induced lymphoma.
Steroid administration after direct decompression sur-
gery aims to prevent secondary injury caused by post-
traumatic spinal ischemia, and to improve neurologic
function and spinal cord blood flow [8]. The key mech-
anism in the theory of secondary injury is posttraumatic
ischemia in the spinal cord with resultant infarction
followed by alterations in microvascular perfusion, in-
flammation, lipid peroxidation, free radical generation,
apoptotic/necrotic cell death, and dysregulation of ionic
homeostasis [9]. Based on this theory of secondary injury
after direct decompression surgery, the patient received
steroid pulse therapy and maintenance therapy at a
physiologic dose. In a previous report, preoperative spinal
angiography in pediatric inferior posterior mediastinal tu-
mors was used to prevent secondary spinal cord ischemia
due to guiding surgical resection [10].
The most common primary malignancies in the poster-
ior mediastinum in children are neurogenic tumors,
accounting for 89% of cases, as reported previously, with
neuroblastoma being the most common of these [11, 12].
Fig. 3 The timeline of treatment including chemotherapy, surgery, and serum β-HCG concentration. We administered methylprednisolone pulse
therapy on day − 8 and alternative ICE and BEP chemotherapy. Moreover, video-assisted thoracoscopic exploration and biopsy were performed
on day + 91. In the serum, β-HCG level was 30.84 mIU/mL before cycle 1. β-HCG level was evaluated in every chemotherapy cycle and was un-
detectable in the blood after cycle 2, as expected
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The child with posterior mediastinum seminoma can be
easily mistaken as having a neurogenic tumor because of
the symptoms and location of tumor origin. Radiographic-
ally, these seminomas appear as large, heterogeneous,
lobulated soft-tissue masses with areas of hemorrhage and
necrosis, and coarse, mottled, ring-shaped calcifications
described in approximately 50% of thoracic neuro-
blastoma [13]. Mediastinal seminomas in children
are typically large, homogeneous, lobulated, and
well-marginated masses in the anterior mediastinum,
but calcification is distinctly uncommon. However, malig-
nant non-seminomatous GCTs differ from those with ir-
regular margins including yolk sac tumor, choriocarcinoma,
embryonal carcinoma, and immature teratoma [14, 15].
In this patient, the serum β-HCG level was increased
but immunohistochemical staining after total laminec-
tomy was negative for β-HCG. This discrepancy might
have been caused by the limited tissue specimen ob-
tained from the emergency surgery for the spinal cord
compression, which was not obtained from the main
mass. After the surgery, further specimens were unavail-
able because of the favorable response to chemotherapy.
Survival rates of pediatric GCTs have dramatically
improved to more than 80% after the introduction of
platinum-based chemotherapy [16]. Current platinum-
based chemotherapy protocols are selected based on age,
site of origin, histology of tumor, stage, completeness of
surgical resection, and treatment response monitored by
tumor markers such as AFP and β-HCG, and via im-
aging studies [17]. The measurement of tumor markers
such as AFP and β-HCG helps to ascertain treatment
response and determine diagnostic and therapeutic
strategies.
An age exceeding 12 years is the most important
factor indicative of poor prognosis of event-free sur-
vival for extragonadal malignant GCTs in children
treated with cisplatin-based therapy. Elevated AFP
and advanced tumor stage are also factors indicative
of poor prognosis [18, 19]. In this case of a GCT, as
the child was 7 years old with a normal serum AFP
level and no evidence of metastasis, a good outcome
is expected.
Spinal cord compression due to a posterior medias-
tinal tumor is considered an oncologic emergency and
is mostly caused by neurogenic tumors. However, we
report an extremely rare case of GCTs not arising
from a neurogenic tumor, such as neuroblastoma. We
treated the patient with emergency decompression
surgery and high-dose steroid pulse therapy to pre-
vent secondary injury to the spinal cord. An ICE/BEP
alternative chemotherapy based on cisplatin was ad-
ministered. He has been followed up regularly for
3 years and is undergoing rehabilitation without any
signs recurrence.
Abbreviations
AFP: α-fetoprotein; ALP: Alkaline phosphatase; BEP: Bleomycin, Etoposide,
and Cisplatin; CT: Computed tomography; GCTs: Germ cell tumors;
HCG: Human chorionic gonadotropin; ICE: Ifosfamide, Carboplatin, and
Etoposide; MRC: Medical Research Council; MRI: Magnetic resonance
imaging; PALP: Placental alkaline phosphatase; VATS: Video-assisted
thoracoscopic surgery
Acknowledgements
The authors would like to thank Dr. Kee Hyun Cho, Dr. Jae woo An, Dr. Joo
Young Song, Dr. Yoo Mi Lee in the Pediatrics Department of CHA Bundang
Medical Center for excellent care of the patient.
Funding
No financial support was received.
Availability of data and materials
The dataset supporting the conclusions of this article is contained within the
manuscript.
Authors’ contributions
DKY was involved in the patient care, and drafted the manuscript. TKA, DES,
and GIK were involved in the patient care and helped to draft the
manuscript and acquired histological images for illustration. MKK was
involved in the patient care and critical revision for content. All authors read
and approved the final manuscript.
Ethics approval and consent to participate
Written informed consent was obtained from the parents for publication of
this case report. And the patient’s parents provided all of information and
samples, and they agree to publish.
Consent for publication
Written informed consent was obtained from the parents of the affected
child patient for publication of clinical case report and any accompanying
images.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Pediatrics, CHA Bundang Medical Center, CHA University
School of Medicine, Seongnam, Republic of Korea. 2Department of
Orthopedic Surgery, CHA Bundang Medical Center, CHA University School of
Medicine, Seongnam, Republic of Korea. 3Department of Pathology, CHA
Bundang Medical Center, CHA University School of Medicine, Seongnam,
Republic of Korea. 4Department of Pediatrics, Severance Hospital, Yonsei
University College of Medicine, Seoul, Republic of Korea.
Received: 3 March 2016 Accepted: 19 February 2018
References
1. Mosbech CH, Rechnitzer C, Brok JS, Rajpert-De Meyts E, Hoei-Hansen CE.
Recent advances in understanding the etiology and pathogenesis of
pediatric germ cell tumors. J Pediatr Hematol Oncol. 2014;36(4):263–70.
2. Pinkerton CR. Malignant germ cell tumours in childhood. Eur J Cancer. 1997;
33(6):895–901. discussion 901-892
3. Bokemeyer C, Nichols CR, Droz J-P, Schmoll H-J, Horwich A, Gerl A, Fossa
SD, Beyer J, Pont J, Kanz L. Extragonadal germ cell tumors of the
mediastinum and retroperitoneum: results from an international analysis.
J Clin Oncol. 2002;20(7):1864–73.
4. Si T, Miyoshi S, Ohta M, Minami M, Masaoka A, Matsuda H. Primary germ
cell tumors in the mediastinum. Cancer. 2003;97(2):367–76.
5. Sizer PS, Brismée JM, Cook C. Medical screening for red flags in the
diagnosis and management of musculoskeletal spine pain. Pain Practice.
2007;7(1):53–71.
Yon et al. BMC Pediatrics  (2018) 18:97 Page 5 of 6
6. Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, Mohiuddin M,
Young B. Direct decompressive surgical resection in the treatment of spinal
cord compression caused by metastatic cancer: a randomised trial. Lancet.
2005;366(9486):643–8.
7. Sandberg DI, Bilsky MH, Kushner BH, Souweidane MM, Kramer K, Laquaglia
MP, Panageas KS, Cheung N-K. Treatment of spinal involvement in
neuroblastoma patients. Pediatr Neurosurg. 2004;39(6):291–8.
8. Tator CH, Fehlings MG. Review of the secondary injury theory of acute
spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg.
1991;75(1):15–26.
9. Lu J, Ashwell KW, Waite P. Advances in secondary spinal cord injury: role of
apoptosis. Spine. 2000;25(14):1859–66.
10. Nordin AB, Fallon SC, Jea A, Kim ES. The use of spinal angiography in the
management of posterior mediastinal tumors: case series and review of the
literature. J Pediatr Surg. 2013;48(9):1871–7.
11. Tansel T, Onursal E, Dayıoğlu E, Başaran M, Sungur Z, Çamcı E, Yılmazbayhan
D, Eker R, Ertuğrul T. Childhood mediastinal masses in infants and children.
Turk J Pediatr. 2006;48:8–12.
12. Saenz NC, Schnitzer JJ, Eraklis AE, Hendren WH, Grier HE, Macklis RM,
Shamberger RC. Posterior mediastinal masses. J Pediatr Surg. 1993;28(2):172–6.
13. Hiorns M, Owens C. Radiology of neuroblastoma in children. Eur Radiol.
2001;11(10):2071–81.
14. Drevelegas A, Palladas P, Scordalaki A. Mediastinal germ cell tumors: a
radiologic–pathologic review. Eur Radiol. 2001;11(10):1925–32.
15. Carter BW, Okumura M, Detterbeck FC, Marom EM. Approaching the patient
with an anterior mediastinal mass: a guide for radiologists. J Thorac Oncol.
2014;9(9):S110–8.
16. Olson TA, Murray MJ, Rodriguez-Galindo C, Nicholson JC, Billmire DF, Krailo
MD, Dang HM, Amatruda JF, Thornton CM, Arul GS, et al. Pediatric and
adolescent extracranial germ cell tumors: the road to collaboration. J Clin
Oncol. 2015;33(27):3018–28.
17. Mann J, Raafat F, Robinson K, Imeson J, Gornall P, Sokal M, Gray E, McKeever
P, Hale J, Bailey S. The United Kingdom Children’s cancer study Group’s
second germ cell tumor study: carboplatin, etoposide, and bleomycin are
effective treatment for children with malignant extracranial germ cell
tumors, with acceptable toxicity. J Clin Oncol. 2000;18(22):3809–18.
18. Marina N, London WB, Frazier AL, Lauer S, Rescorla F, Cushing B,
Malogolowkin MH, Castleberry RP, Womer RB, Olson T. Prognostic factors in
children with extragonadal malignant germ cell tumors: a pediatric
intergroup study. J Clin Oncol. 2006;24(16):2544–8.
19. Baranzelli M, Kramar A, Bouffet E, Quintana E, Rubie H, Edan C, Patte C.
Prognostic factors in children with localized malignant nonseminomatous
germ cell tumors. J Clin Oncol. 1999;17(4):1212.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Yon et al. BMC Pediatrics  (2018) 18:97 Page 6 of 6
